JAMS decides biotech IP dispute
A JAMS arbitrator has reportedly rejected a California biotech company’s claim that one of its co-founders misappropriated trade secrets relating to developing treatments for neurodegenerative diseases.
To read more
Subscribe to Global Arbitration Review
Subscribe and start reading now
Global Arbitration Review (GAR) is the online home for international arbitration specialists, telling them everything they need to know about all the developments that matter.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10